Du, Zhenfang http://orcid.org/0000-0001-6364-1321
Brown, Benjamin P.
Kim, Soyeon
Ferguson, Donna
Pavlick, Dean C.
Jayakumaran, Gowtham
Benayed, Ryma http://orcid.org/0000-0002-3754-0321
Gallant, Jean-Nicolas http://orcid.org/0000-0003-4696-2013
Zhang, Yun-Kai
Yan, Yingjun
Red-Brewer, Monica
Ali, Siraj M.
Schrock, Alexa B.
Zehir, Ahmet http://orcid.org/0000-0001-5406-4104
Ladanyi, Marc
Smith, Adam W.
Meiler, Jens
Lovly, Christine M. http://orcid.org/0000-0002-3641-6361
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01CA227833, R01GM080403, P30CA086485, UG1CA233259, 5P01CA129243-12, R01GM080403, R01GM099842, R01GM073151, F30DK118774)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
National Science Foundation (CHE-1753060)
U.S. Department of Health & Human Services | National Institutes of Health
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (P30CA008748)
Article History
Received: 19 March 2020
Accepted: 28 January 2021
First Online: 2 March 2021
Competing interests
: D.C.P., S.M.A., and A.B.S. are employees of Foundation Medicine, Inc. C.M.L. is a consultant/advisory board member for Pfizer, Novartis, Astra Zeneca, Genoptix, Genentech, Syros, Cepheid, Roche, Sequenom, Ariad, Takeda, Foundation Medicine, Blueprints Medicine, Achilles, Amgen and reports receiving commercial research grants from Xcovery and Novartis. M.L. has received advisory board compensation from Merck, Lilly Oncology, AstraZeneca, Bristol-Myers Squibb, Takeda, and Bayer, and research support from LOXO Oncology, Helsinn Healthcare, Elevation Oncology and Merus. No potential conflicts of interest were disclosed by the other authors.